Holdouts from the pharmaceutical giant's $10 billion settlement offer aim to question the legitimacy of the bankruptcy altogether.
Share this post
Ossowski: A narrow window for justice in…
Share this post
Holdouts from the pharmaceutical giant's $10 billion settlement offer aim to question the legitimacy of the bankruptcy altogether.